Smilow Cancer Hospital at Yale - New Haven — New Haven, Connecticut

Smilow Cancer Hospital at Yale - New Haven is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital at Yale - New Haven has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Liposarcoma, Prostate Cancer, Breast Neoplasms.

Sponsors: Pfizer, TORL Biotherapeutics, LLC, Leap Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital at Yale - New Haven?

Smilow Cancer Hospital at Yale - New Haven has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital at Yale - New Haven conducted?

Smilow Cancer Hospital at Yale - New Haven has 6 clinical trials on record, with 4 currently active. Their work covers Liposarcoma, Prostate Cancer, Breast Neoplasms.

Is Smilow Cancer Hospital at Yale - New Haven accredited by Crixeo Health?

Yes — Smilow Cancer Hospital at Yale - New Haven holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Smilow Cancer Hospital at Yale - New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.